Spevigo

Quote

anonymous said:
Goal is never adjusted down you idiot. Only up. And considering how poorly Spevigo has performed this year (just like previous years) it’s likely that this drug has little time left.BI should sell the asset off to a smaller biotech and let them try to resuscitate it. Take some money now to recoup the loss. Move existing sales force over to the mental health (if that even launches) digital therapeutic and hope for the best.
Click to expand...
Hey “idiot”….other divisions HAVE adjusted goals down. I know of 3 times where this has happened.
 


anonymous said:
Hey “idiot”….other divisions HAVE adjusted goals down. I know of 3 times where this has happened.
Click to expand...
The number we owe Germany at the end of the year is the budget goal. That number doesn’t change you fuckstick. Maybe your territory goal adjusts slightly, but BI is still on the hook for their inability to properly forecast an achievable goal with some stretch.
 


















anonymous said:
Is this the next division to get cut? Numbers didn’t look good for January and division running in the red. Patience must be running thin.
Click to expand...
Pressure is on, their conference spending, boondoggles for non essential employees to attend conferences in Island locations.They should be playing small but legacy BI folks are acting like it's Ofev part two. No new ideas, just rinse and repeat from 2015 or 1999.
 








anonymous said:
Great news for AAD for a great drug!!
Click to expand...
Great news or Fake news? ADD was a total copy and paste, or copy and waste of last year. HCP meetings were meh. Unless they are being paid derms could care less about GPP or the drug. Besides most of marketing folks are lame and don't get it. Our competitors are laughing at us. What's with that new marketing chick, real bossy and thinks she knows everything and everyone, she is a bitch.

Time to jump, Summer won't be pretty. I was once excited, now I'm not.
 


anonymous said:
Great news or Fake news? ADD was a total copy and paste, or copy and waste of last year. HCP meetings were meh. Unless they are being paid derms could care less about GPP or the drug. Besides most of marketing folks are lame and don't get it. Our competitors are laughing at us. What's with that new marketing chick, real bossy and thinks she knows everything and everyone, she is a bitch.

Time to jump, Summer won't be pretty. I was once excited, now I'm not.
Click to expand...
Sorry *AAD. Early morning start.
 


anonymous said:
Great news or Fake news? ADD was a total copy and paste, or copy and waste of last year. HCP meetings were meh. Unless they are being paid derms could care less about GPP or the drug. Besides most of marketing folks are lame and don't get it. Our competitors are laughing at us. What's with that new marketing chick, real bossy and thinks she knows everything and everyone, she is a bitch.

Time to jump, Summer won't be pretty. I was once excited, now I'm not.
Click to expand...
There is no new Marketing Chick? Maybe provide a description?
 




anonymous said:
She said marketing liaison, not sales. Older, blondish, chubby and new to BI. I just stayed clear.

Great drug, but no one sees GPP or they don't diagnose it. No body is happy in this TA. Doesn't feel stable or right.
Click to expand...
Poster literally said “Marketing Chick”. Nothing about Liaison. And how did you know it was a “she” that said it?
 


anonymous said:
Great news or Fake news? ADD was a total copy and paste, or copy and waste of last year. HCP meetings were meh. Unless they are being paid derms could care less about GPP or the drug. Besides most of marketing folks are lame and don't get it. Our competitors are laughing at us. What's with that new marketing chick, real bossy and thinks she knows everything and everyone, she is a bitch.

Time to jump, Summer won't be pretty. I was once excited, now I'm not.
Click to expand...
What competitors?
 



Write your reply...
Top Bottom
Back
Quote